In anticipation of ESMO 2018

Written by Sean McGrath on Monday 15th October 2018

The European Society for Medical Oncology (ESMO) annual meeting is by far Europe’s largest clinical and research-based cancer meeting with an estimated 25,000 delegates attending the congress in Munich. Along with ASCO, it’s where the most important data breakthroughs are presented, new therapies/modalities are unveiled, and world-renowned experts discuss the topics at the forefront of everyone’s minds.

Sean McGrath, Director of Oncology at OPEN Health, will be attending ESMO 2018. In anticipation of the meeting at the end of this week, Sean gives us the lowdown on what he is most looking forward to hearing about and his predications for this exciting congress.

For further information about OPEN Health and the specialist businesses within our group, please contact Carwyn Jones Partnerships Director at OPEN Health